BSE Live
Nov 03, 16:01Prev. Close
437.75
Open Price
439.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 03, 15:59Prev. Close
437.90
Open Price
440.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
431.85 (169)
| Profit & Loss account of Panacea Biotec (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 643.63 | 467.80 | 531.54 | 689.36 | 1,130.82 | |
| Less: Excise/Sevice Tax/Other Levies | 0.41 | 0.66 | 1.12 | 0.98 | 0.36 | |
| Revenue From Operations [Net] | 643.22 | 467.14 | 530.42 | 688.38 | 1,130.46 | |
| Total Operating Revenues | 679.20 | 503.03 | 595.92 | 700.58 | 1,149.83 | |
| Other Income | 28.05 | 11.64 | 5.43 | 7.46 | 15.68 | |
| Total Revenue | 707.25 | 514.67 | 601.35 | 708.04 | 1,165.51 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 241.42 | 196.58 | 236.37 | 302.12 | 447.39 | |
| Purchase Of Stock-In Trade | 20.79 | 22.39 | 23.26 | 24.52 | 24.44 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 26.39 | -10.89 | 0.29 | 20.56 | 58.87 | |
| Employee Benefit Expenses | 133.23 | 142.73 | 137.23 | 150.45 | 154.31 | |
| Finance Costs | 93.17 | 148.05 | 105.74 | 101.11 | 55.75 | |
| Depreciation And Amortisation Expenses | 65.74 | 68.80 | 83.54 | 75.39 | 73.11 | |
| Other Expenses | 189.85 | 244.45 | 282.86 | 296.84 | 196.15 | |
| Total Expenses | 770.59 | 812.11 | 869.29 | 970.99 | 1,010.02 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -63.34 | -297.44 | -267.94 | -262.95 | 155.49 | |
| Exceptional Items | 0.00 | 297.02 | 17.31 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -63.34 | -0.42 | -250.63 | -262.95 | 155.49 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 1.89 | 0.00 | 0.00 | 0.00 | 32.46 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 17.48 | |
| Deferred Tax | 0.00 | 0.00 | -20.50 | -55.16 | 4.77 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.69 | |
| Total Tax Expenses | 1.89 | 0.00 | -20.50 | -55.16 | 20.44 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -65.23 | -0.42 | -230.13 | -207.79 | 135.05 | |
| Profit/Loss From Continuing Operations | -65.23 | -0.42 | -230.13 | -207.79 | 135.05 | |
| Profit/Loss For The Period | -65.23 | -0.42 | -230.13 | -207.79 | 135.05 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -10.65 | -0.07 | -37.57 | -33.92 | 21.35 | |
| Diluted EPS (Rs.) | -10.65 | -0.07 | -37.57 | -33.92 | 21.35 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 136.58 | 103.97 | 152.11 | 217.05 | 303.39 | |
| Indigenous Raw Materials | 104.84 | 92.61 | 84.26 | 85.07 | 144.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 1.36 | 3.17 | 3.33 | 2.69 | 2.44 | |
| Indigenous Stores And Spares | 15.28 | 14.51 | 18.17 | 18.42 | 18.54 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 4.59 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.75 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 75.00 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y